NIH-funded research R01 grant

Exploring how epigenetic changes affect Down syndrome using human cell models

Official title: Investigating epigenetic mechanisms in Down syndrome using human cellular models

Funded at Broad Institute, INC. · NIH-10655152 · Data updated 2026-11-12

This study is looking at how certain changes in our genes might affect people with Down syndrome, using special lab-grown cells to better understand how these changes can influence their health and development.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBroad Institute, INC.
NIH-funded
Lab location1 site (Cambridge, United States)
Project startApril 5, 2023
Project endMarch 31, 2026
Funding year2023
Award (this year)$2,034,753
NIH project number1R01HD111876-01
Project IDNIH-10655152 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Down syndrome, particularly those interested in contributing to advancements in understanding the condition.

Less likely to help

Patients without Down syndrome or those with other unrelated genetic conditions may not benefit from this research.

What this research studies

This research investigates the epigenetic mechanisms that contribute to Down syndrome, which is caused by an extra copy of chromosome 21. By utilizing human induced pluripotent stem cell models, the study aims to analyze changes in histone modifications that may influence gene expression and cellular function in individuals with Down syndrome. The researchers will conduct a comprehensive examination of how these epigenetic alterations impact the biology of the condition, moving beyond traditional gene-focused approaches. This innovative methodology seeks to uncover new insights into the underlying mechanisms of Down syndrome.

Why it matters

Potential benefit: If successful, this research could lead to a better understanding of Down syndrome and potentially identify new therapeutic targets for improving patient outcomes.

How similar studies have gone: While the exploration of epigenetic mechanisms in Down syndrome is relatively novel, similar approaches in other genetic conditions have shown promising results.

Where this research is happening

  • Broad Institute, INC.
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Barrett, Lindy Elise — Broad Institute, INC.
  • Study coordinator: Barrett, Lindy Elise

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.